ArticlePloS one2025
Artificial intelligence-based CT histogram parameters differentiating bronchiolar adenoma and lung adenocarcinomas: A two-center study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBronchiolar adenoma (BA) is a rare benign pulmonary neoplasm originating from the bronchial mucosal epithelium and mimics lung adenocarcinoma (LAC) both radiographically and microscopically. This study aimed to develop a nomogram for distinguishing BA from LAC by integrating clinical characteristics and artificial intelligence (AI)-derived histogram parameters across two medical centers.
methodsThis retrospective study included 215 patients with diagnoses confirmed by postoperative pathology from two medical centers. Medical center 1 provided 151 patients (68 BA and 83 LAC nodules) as the training cohort, while medical center 2 contributed 64 patients (28 BA and 36 LAC nodules) as the external validation cohort. Risk predictors and the nomogram were developed using clinical characteristics and AI-derived histogram parameters.
resultsNodule density (solid, ground glass, and subsolid) exhibited a statistically significant difference between the BA and LAC groups (p < 0.01). The following parameters were significantly higher in the LAC group compared to the BA group (all p < 0.05): 2D long diameter, 2D short diameter, 2D average diameter, 2D maximum surface area, 3D long diameter, 3D surface area, 3D volume, and entropy. In contrast, CT value variance was significantly lower in the LAC group than in the BA group (p < 0.01). A nomogram was constructed incorporating density, 2D short diameter, and CT value variance. The area under the curve (AUC) of the nomogram in the training and validation cohorts were 0.821, 0.811.
conclusionThe AI-based nomogram, as a non-invasive preoperative tool, had the potential to enhance diagnostic accuracy for distinguishing BA from LAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.